GLS1 INHIBITOR FOR TREATING DISEASES

To provide a glutaminase inhibitor effective for GLSI inclusive diseases such as cancer, immune disorder, and neurological disorder.SOLUTION: There is provided a compound represented by the formula III, where n is 3, 4, or 5; Rand Rare alkyl, cyano, H or halogen, or the like; Ais C or N; A, A, and A...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LIU GANG, BARBARA CZAKO, ANNE YAU, TIMOTHY HEFFERNAN, MARIA EMILIAFRANCESCO, JASON P BURKE, LEE KANG, ZACHARY HERRERA, WYLIE S PALMER, JAY THEROFF, PHILIP JONES, RICHARD LEWIS, MICHAEL P SOTH, TIMOTHY MCAFOOS, MATTHEW M HAMILTON, CHRISTOPHER LAWRENCE CARROLL, KANG ZHIJUN
Format: Patent
Sprache:eng ; jpn
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To provide a glutaminase inhibitor effective for GLSI inclusive diseases such as cancer, immune disorder, and neurological disorder.SOLUTION: There is provided a compound represented by the formula III, where n is 3, 4, or 5; Rand Rare alkyl, cyano, H or halogen, or the like; Ais C or N; A, A, and Aare N, O, S or CH;Zis C; Z, Z, Zare N or CH; and R, R, R, Rrepresent a specific substituent.SELECTED DRAWING: None 【課題】癌、免疫障害、及び神経障害等の、GLSI介在性障害に有効なグルタミナーゼ阻害薬の提供。【解決手段】式IIIで示される化合物。[式中、nは3、4、又は5;RX、RYは、アルキル、シアノ、H又はハロゲン等;A1はC又はN;A2、A3、A4は、N、O、S又はCH;Z1はC;Z2、Z3、Z4はN又はCH;R1、R2、R3,R6は特定の置換基を表す]【選択図】なし